49 results
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
applicable regulatory authorities, including the European Medicines Agency and the UK Medicines & Healthcare products Regulatory Agency (collectively … , regulations and directives of applicable government funded or sponsored healthcare programs, and the regulations promulgated pursuant to such statutes
8-K
CNTA
Centessa Pharmaceuticals plc
10 Jun 24
Departure of Directors or Certain Officers
7:13am
. Before Axovant, Dr. Weinhoff spent 15 years as an early-stage healthcare venture capitalist at CHL Medical Partners, where he was founding CEO … healthcare corporate finance group. Dr. Weinhoff holds an MD degree from Harvard Medical School, and MBA from Harvard Business School, and an AB
8-K
EX-99.1
CNTA
Centessa Pharmaceuticals plc
10 Jun 24
Departure of Directors or Certain Officers
7:13am
financings. Before Axovant, Dr. Weinhoff spent 15 years as an early-stage healthcare venture capitalist at CHL Medical Partners, where he … healthcare corporate finance group. About Centessa Pharmaceuticals Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims
PRE 14A
us7j0l1l ul
26 Apr 24
Preliminary proxy
4:36pm
8-K
EX-1.1
ont95 omsynfslut16
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
8-K
yrs3q
8 Jul 22
Departure of Directors or Certain Officers
4:32pm
DEF 14A
aotq8m7q7 onuyss4t
23 May 22
Definitive proxy
8:00am